Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Treated on Clinical Trial CCLG-GC-1979-01 or CCLG-GC-1989-01

计划入组 60 人 · 首次发布于 2007 年 2 月 19 日

GC-PRO Intervention

计划入组 994 人 · 首次发布于 2024 年 11 月 4 日

First-line Gemcitabine/Cisplatin +/- Avelumab in Locally Advanced or Metastatic Bladder Carcinoma

计划入组 65 人 · 首次发布于 2017 年 10 月 27 日

GC-PS05

GC-3113

Diphtheria-tetanus vaccine(Green Cross)

GREEN CROSS CORPORATION

India

GC CELL CORPORATION

South Korea

GC Biopharma Corp.

South Korea

GC Green Cross Submits Phase 1 Clinical Trial Application for COVID-19 mRNA Vaccine in South Korea

GC Pharma Unveils AI-Driven mRNA-LNP Platform, Advances COVID-19 Vaccine Toward Phase 2 Trial

GC Wellbeing Licenses Raziel's Next-Generation Fat-Dissolving Injectable, Eyes Phase 3 Entry